BridgeMD
New treatment option for Patients With Spinal Stenosis Indicated for MIS TLIF
Official title ESP Block in MIS Lumbar Spine Surgery
ClinicalTrials.gov ID: NCT05856539
What this study is testing
- What it's testing
- This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18-80
- Patients scheduled for MIS TLIF (any level) with the principal investigator
- ASA 1, 2, 3
You likely can't join if
- ASA 4 or higher
- BMI \>40
- Chronic opioid use (daily use for \> 3 months)
- Revision surgery, any history of previous lumbar spine surgery
- Allergy to any of the study medications
- Non-English speaking
See the full eligibility criteria
- Age 18-80
- Patients scheduled for MIS TLIF (any level) with the principal investigator
- ASA 1, 2, 3
- ASA 4 or higher
- BMI \>40
- Chronic opioid use (daily use for \> 3 months)
- Revision surgery, any history of previous lumbar spine surgery
- Allergy to any of the study medications
- Non-English speaking
- Chronic renal insufficiency or failure (creatinine \>2) or severe hepatic disease (cirrhosis, failure)
- Pregnancy
- Any concomitant surgery
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.